Current advances related to Clostridium difficile infection.
Artículo
en Inglés
| IMSEAR
| ID: sea-158443
ABSTRACT
Clostridium difficile infection (CDI) can trigger various responses, ranging from asymptomatic carriage to fulminant colitis. Hard-to-cure CDI, such as severe CDI, multiple recurrences of CDI, refractory CDI, and hypervirulent strains of C. difficile, require new treatments, although antibiotics such as metronidazole and vancomycin are the treatment of choice for initial and first relapsing CDI. Active immunization with C. difficile toxins and faecal microbiota transplantation deserve special attention. Here we describe these strategies for difficult-to-treat CDI.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Humanos
/
Vacunas Bacterianas
/
Vacunas
/
Clostridioides difficile
/
Control de Infecciones
/
Infecciones por Clostridium
/
Trasplantes
Idioma:
Inglés
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS